［1］RL Siegel,KD Miller,A Jemal,et al.Cancer statistics［J］.CA Cancer J Clin,2016,66(4):7-30.
［2］Q He,Y Liu,W Sun,et al.Statistical analysis of non-coding RNA data［J］.Cancer Letter,2018,417(5):161-167.
［3］CM Klinge.Non-coding RNAs:Long non-coding RNAs and microRNAs in endocrine-related cancers［J］.Endocr Relat Cancer,2018,25(5):259-282.
［4］E Anastasiadou,LS Jacob,FJ Slack，et al.Non-coding RNA networks in cancer［J］.Nat Rev Cancer,2018,18(2):5-18.
［5］Y Su,H Wu,A Pavlosky,et al.Regulatory non-coding RNA:New instruments in the orchestration of cell death［J］.Cell Death Dis,2016,7(3):e2333.
［6］G St Laurent,C Wahlestedt,P Kapranov,et al.The landscape of long noncoding RNA classification［J］.Trends Genet,2015,31(8):239-251.
［7］X Xue,YA Yang,A Zhang,et al.LncRNA HOTAIR enhances ER signaling and confers tamoxifen resistance in breast cancer［J］.Oncogene,2016,35(3):2746-2755.
［8］X Li,Z Wu,X Fu,et al.lncRNAs:Insights into their function and mechanics in underlying disorders［J］.Mutat Res Rev Mutat Res,2014,762(5):1-21.
［9］JE Wilusz,H Sunwoo,DL Spector,et al.Long noncoding RNAs:functional surprises from the RNA world［J］.Genes Dev,2009,23（4）:1494-1504.
［10］Y Ma,P Zhang,F Wang,et al.The relationship between early embryo development and tumourigenesis［J］.J Cell Mol Med,2010,14(9):2697-2701.
［11］Y Sun,J Pan,N Zhang,et al.Knockdown of long non-coding RNA H19 inhibits multiple myeloma cell growth via NF-kappa B pathway［J］.Sci Rep,2017,7(2):18079.
［12］M Medrzycki,Y Zhang,W Zhang,et al.Histone h1.3 suppresses h19 noncoding RNA expression and cell growth of ovarian cancer cells［J］.Cancer Res,2014,74(5):6463-6473.
［13］GW Verhaegh,L Verkleij,SH Vermeulen,et,al.Polymorphisms in the H19 gene and the risk of bladder cancer［J］.Eur Urol,2008,54(7):1118-1126.
［14］WP Tsang,TT Kwok.Riboregulator H19 induction of MDR1-associated drug resistance in human hepatocellular carcinoma cells［J］.Oncogene,2007,26(2):4877-4881.
［15］Q Zhang,X Li,X Li,et al.LncRNA H19 promotes epithelial-mesenchymal transition (EMT) by targeting miR-484 in human lung cancer cells［J］.Peer J,2018,119(3):4447-4457.
［16］Y Wei,Z Liu,J Fang.H19 functions as a competing endogenous RNA to regulate human epidermal growth factor receptor expression by sequestering let7c in gastric cancer［J］.Mol Med Rep,2018,17(7):2600-2606.
［17］E Raveh,IJ Matouk,M Gilon,et al.The H19 Long non-coding RNA in cancer initiation,progression and metastasis - a proposed unifying theory［J］.Mol Cancer,2015,14(8):184.
［18］F Peng,TT Li,KL Wang,et al.H19/let-7/LIN28 reciprocal negative regulatory circuit promotes breast cancer stem cell maintenance［J］.Cell Death Dis,2017,8(1):e2569.
［19］PC Schouten,MA Vollebergh,M Opdam,et al.High XIST and low 53BP1 expression predict poor outcome after high-dose alkylating chemotherapy in patients with a BRCA1-like breast cancer［J］.Mol Cancer Ther,2016,15(4):190-198.
［20］P Sosinska,J Mikula-Pietrasik,K Ksiazek,et al.The double-edged sword of long non-coding RNA:The role of human brain-specific BC200 RNA in translational control,neurodegenerative diseases,and cancer［J］.Mutat Res Rev Mutat Res,2015,766(5):58-67.
［21］RH Zhao,CH Zhu,XK Li,et al.BC200 LncRNA a potential predictive marker of poor prognosis in esophageal squamous cell carcinoma patients［J］.Onco Targets Ther,2016,9(2):2221-2226.
［22］K Wu,K Xu,K Liu,et al.Long noncoding RNA BC200 regulates cell growth and invasion in colon cancer［J］.Int J Biochem Cell Biol,2018,99(8):219-225.
［23］DI Wu,T Wang,C Ren,et al.Downregulation of BC200 in ovarian cancer contributes to cancer cell proliferation and chemoresistance to carboplatin［J］.Oncol Lett,2016,11(7):1189-1194.
［24］J Peng,F Hou,J Feng,et al.Long non-coding RNA BCYRN1 promotes the proliferation and metastasis of cervical cancer via targeting microRNA-138 in vitro and in vivo［J］.Oncol Lett,2018,15(8):5809-5818.
［25］H Ren,X Yang,Y Yang，et al.Upregulation of LncRNA BCYRN1 promotes tumor progression and enhances EpCAM expression in gastric carcinoma［J］.Oncotarget,2018，9(3):4851-4861.
［26］T Hu,YR Lu.BCYRN1,a c-MYC-activated long non-coding RNA,regulates cell metastasis of non-small cell lung cancer［J］.Cancer Cell Int,2015,15(8):36.
［27］EP Booy,EK McRae,A Koul,et al.The long non-coding RNA BC200 (BCYRN1) is critical for cancer cell survival and proliferation［J］.Mol Cancer,2017,16(9):109.
［28］S Chooniedass-Kothari,MK Hamedani,S Troup,et al.The steroid receptor RNA activator protein is expressed in breast tumor tissues［J］.Int J Cancer,2006,118(9):1054-1059.
［29］RL Milne,AC Antoniou.Modifiers of breast and ovarian cancer risks for BRCA1 and BRCA2 mutation carriers［J］.Endocr Relat Cancer,2016,23(8):69-84.
［30］A Vincent-Salomon,C Ganem-Elbaz,E Manie,et al.X inactive-specific transcript RNA coating and genetic instability of the X chromosome in BRCA1 breast tumors［J］.Cancer Res,2007,67(5):5134-5140.
［31］M Jiang,O Huang,Z Xie,et al.Shen,A novel long non-coding RNA-ARA:Adriamycin resistance-associated［J］.Biochem Pharmaco,2014,187(8):254-283.
［32］JD Waters,DD Gonda,H Reddy,et al.Diagnostic yield of stereotactic needle-biopsies of sub-cubic centimeter intracranial lesions［J］.Surg Neurol Int,2013,4(8):176-181.
［33］P Hou,Y Zhao,Z Li,et al.LincRNA-ROR induces epithelial-to-mesenchymal transition and contributes to breast cancer tumorigenesis and metastasis［J］Cell Death Dis,2014,5(9):e1287.
［34］WX Peng,JG Huang,L Yang,et al.Linc-RoR promotes MAPK/ERK signaling and confers estrogen-independent growth of breast cancer［J］.Mol Cancer,2017,16(7):161.
［35］E Latorre,S Carelli,I Raimondi,et al.The ribonucleic complex HuR-MALAT1 represses CD133 expression and suppresses epithelial-mesenchymal transition in breast cancer［J］.Cancer Res,2016,76(2)：2626-2636.
［36］J Chou,B Wang,T Zheng,et,al.MALAT1 induced migration and invasion of human breast cancer cells by competitively binding miR-1 with cdc42［J］.Biochem Biophys Res Commun，2016，472(9)：262-269.
［37］Z Li,P Hou,D Fan,et al.The degradation of EZH2 mediated by lncRNA ANCR attenuated the invasion and metastasis of breast cancer［J］.Cell Death Differ，2017，24(7):59-71.
［38］J Ye,R Zhang,F Wu,et al.Non-apoptotic cell death in malignant tumor cells and natural compounds［J］.Cancer Lett,2018,420(9):210-227.
［39］M Mourtada-Maarabouni,MR Pickard,VL Hedge,et al.GAS5,a non-protein-coding RNA,controls apoptosis and is downregulated in breast cancer［J］.Oncogene,2009,28(8):195-208.
［40］L Han,P Ma,SM Liu,et al.Circulating long non-coding RNA GAS5 as a potential biomarker in breast cancer for assessing the surgical effects［J］.Tumour Biol,2016,37(2):6847-6854.
［41］Z Zou,T Ma,X He,et al.Long intergenic non-coding RNA 00324 promotes gastric cancer cell proliferation via binding with HuR and stabilizing FAM83B expression［J］.Cell Death Dis,2018,9(7):717.
［42］X Li,S Wang,Z Li,et al.The lncRNA NEAT1 facilitates cell growth and invasion via the miR-211/HMGA2 axis in breast cancer［J］.Int J Biol Macromol,2017,105(5):346-353.
［43］ L Huang,L Zeng,J Chu,et al.Chemoresistancerelated long noncoding RNA expression profiles in human breast cancer cells［J］.Mol Med Rep,2018,61(8):65.
［44］DF Gradia,C Mathias.Long non-coding RNA TUG1 expression is associated with different subtypes in human breast cancer［J］.Noncoding RNA,2017,3(6):20.